Icaritin
CAS No. 118525-40-9
Icaritin( Icaritin )
Catalog No. M17860 CAS No. 118525-40-9
Icaritin has hormone regulation activity and cardiovascular function improvement activity. Icaritin has anticancer activity, can induce S phase arrest and apoptosis, inhibit ENKL cell proliferation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 57 | In Stock |
|
10MG | 105 | In Stock |
|
25MG | 177 | In Stock |
|
50MG | 264 | In Stock |
|
100MG | 394 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIcaritin
-
NoteResearch use only, not for human use.
-
Brief DescriptionIcaritin has hormone regulation activity and cardiovascular function improvement activity. Icaritin has anticancer activity, can induce S phase arrest and apoptosis, inhibit ENKL cell proliferation.
-
DescriptionIcaritin is an oral traditional Chinese medicine, derived from barrenwort, which targets the estrogen receptor α36. IC50 values for Icaritin are 8,13 and 18 μM for K562, CML-CP and CML-BC cells respectively. Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1α signalling. Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway. Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells.
-
In VitroCell Proliferation Assay Cell Line:K562, imatinib-resistant cells and primary CML cells Concentration:4 μM, 8 μM, 16 μM, 32 μM and 64 μM Incubation Time:48 hours Result:Inhibited cell proliferation.Apoptosis Analysis Cell Line:K562 or primary cells Concentration:0 μM, 4 μM, 8 μM, 16 μM, 32 μM and 64 μM Incubation Time:48 hours Result:Induced K562 or primary cells apoptosis.Cell Cycle Analysis Cell Line:K562 cells Concentration: 32 μM Incubation Time:Result:Cell population in the sub-G1 phase was increased.Western Blot Analysis Cell Line:K562 cells Concentration:0 μM, 4 μM, 8 μM, 16 μM, 32 μM and 64 μM Incubation Time:48 hours Result:Inhibited MAPK/ERK/JNK downstream signaling and diminishes Jak2/Stat3/Akt expression.
-
In VivoAnimal Model:Female NOD-SCID nude mice (6-8 weeks old) with K562 cells Dosage:4 mg/kg and 8 mg/kg Administration:Intraperitoneal injection; daily; for 10 weeks Result:Could prolong lifespan of NOD-SCID nude mice inoculated with K562 cells without suppression of bone marrow.
-
SynonymsIcaritin
-
PathwayOthers
-
TargetOther Targets
-
RecptorJAK2| STAT3
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number118525-40-9
-
Formula Weight368.38
-
Molecular FormulaC21H20O6
-
Purity>98% (HPLC)
-
SolubilityDMSO : 14 mg/mL 38.00 mM;
-
SMILESCC(=CCc1c(cc(c2c1oc(c(c2=O)O)c1ccc(cc1)OC)O)O)C
-
Chemical Name3,5,7-Trihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhu S, et al. Oncotarget. 2015 Apr 30;6(12):10460-72.
molnova catalog
related products
-
Pramiracetam
A central nervous system stimulant and nootropic agent; shows cognition-restoring and neuroprotective properties.
-
Thalidomide-5-methyl
Thalidomide-5-methyl is the Thalidomide-based cereblon (CRBN) ligand used in the recruitment of CRBN protein.
-
Filixic acid ABA
Filixic acid ABA exhibits inhibitory effects on neuraminidase of influenza virus H5N1 with IC50 as 29.57 ± 2.48 μM, it may have anti-influenza virus activity.